Inclusion of children and young people in clinical trials across Europe

The Cross-Border Access to Paediatric Clinical Trials Working Group (WG) created by the European Network of Paediatric Research at the European Medicines Agency is aiming to facilitate the inclusion of children and young people in clinical trials across Europe avoiding any language barriers. 

The group are interested to hear from parents of children living with a condition via a survey.  They group plan to analyse:

• how access to cross-border clinical trials in Europe for paediatric patients is managed in terms of language barriers, and;

• even if your child has no experience of participating in a clinical trial, the group would like to know your preferences.

The link to the survey is here. The answers to this questionnaire are anonymous.

PLEASE NOTE:
This work is done by the Working Group of Paediatric Clinical Trials Cross-border Access in Europe, operating under the European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA). The Working Group leader is Begonya Nafria (PhD Candidate) from Sant Joan de Déu Children´s Hospital in Spain. All the data and information produced for this Working Group have been approved by the Sant Joan de Déu Research Foundation's Ethics Committee.